Related references
Note: Only part of the references are listed.MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation
Nicole Konig et al.
JOURNAL OF NEUROLOGY (2021)
International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
Pushpa Narayanaswami et al.
NEUROLOGY (2021)
Risk factors of myasthenia crisis after thymectomy among myasthenia gravis patients A meta-analysis
Yingcai Geng et al.
MEDICINE (2020)
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases
Bernhard Neumann et al.
NEUROLOGY (2020)
Factors associated with acute exacerbations of myasthenia gravis
Rohit Reddy Gummi et al.
MUSCLE & NERVE (2019)
Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis
Mingxia Li et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Understanding the burden of refractory myasthenia gravis
Christiane Schneider-Gold et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
Renato Mantegazza et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis
Liang Xue et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)
Predictors of extubation outcomes following myasthenic crisis
Zhenguo Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2016)
Myasthenia gravis - autoantibody characteristics and their implications for therapy
Nils Erik Gilhus et al.
NATURE REVIEWS NEUROLOGY (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Randomized Trial of Thymectomy in Myasthenia Gravis
G. I. Wolfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognostic factors for exacerbations and emergency treatments in myasthenia gravis
Robert H. P. de Meel et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
MINIMAL CLINICALLY IMPORTANT DIFFERENCE IN MYASTHENIA GRAVIS: OUTCOMES FROM A RANDOMIZED TRIAL
Hans D. Katzberg et al.
MUSCLE & NERVE (2014)
ANTI-MuSK ANTIBODY MYASTHENIA GRAVIS: CLINICAL FINDINGS AND RESPONSE TO TREATMENT IN TWO LARGE COHORTS
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
A. Alshekhlee et al.
NEUROLOGY (2009)
Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience
Lorenzo Maggi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity
RS Bedlack et al.
NEUROLOGY (2005)
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
A Evoli et al.
BRAIN (2003)
Myasthenia gravis - Recommendations for clinical research standards
A Jaretzki et al.
NEUROLOGY (2000)
Share Paper
